As critically short telomeres are a hallmark of genomic instability associated to carcinogenesis and may be considered a marker of field cancerization (26, 27), is not surprising that patients harbouring the -124 C>T TERT promoter mutation showed a significantly increased risk of tumour relapse. Here, TERT is linked to neoplasm.